Basics Xeris Pharmaceuticals, Inc. IPO Date: June 22, 2018 Sector: Healthcare Market Cap: $1.08B Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.37% Avg Daily Range (30 D): $0.17 | 2.12% Avg Daily Range (90 D): $0.16 | 2.10% Institutional Daily Volume Avg Daily Volume: 1.46M Avg Daily Volume (30 D): 2.29M Avg Daily Volume (90 D): 2.22M Trade Size Avg Trade Size (Sh.): 214 Avg Trade Size (Sh.) (30 D): 110 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 459 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $1.54M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $1.56M Avg Closing Trade (90 D): $2.08M Avg Closing Volume: 365.83K     News Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.1 $ $-.01 Diluted EPS $-.1 $ $-.01 Revenue $ 266.14M $ 74.38M $ 71.54M Gross Profit $ $ $ Net Income / Loss $ -15.64M $ .62M $ -1.93M Operating Income / Loss $ 9.8M $ 6.73M $ 4.48M Cost of Revenue $ $ $ Net Cash Flow $ 32.26M $ 32.21M $ .85M PE Ratio